Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2016 Apr 9;387(10027):1507-1508.
doi: 10.1016/S0140-6736(16)30125-8. Epub 2016 Apr 7.

HIV moments and pre-exposure prophylaxis

Robert M Grant  1 , David V Glidden  2
Affiliations
Comment

HIV moments and pre-exposure prophylaxis

Robert M Grant et al. Lancet. .
No abstract available

PubMed Disclaimer

Figures

Figure
Figure. Temporal variation in sexual practices involving HIV risk
Each row represents one person who seroconverted in the placebo group of the iPrEx trial of pre-exposure prophylaxis in men who have sex with men and transgender women. Non-condom receptive anal intercourse was reported most frequently at enrolment, and sporadically thereafter.
See this image and copyright information in PMC

Comment in

Comment on

References

    1. McCormack S, Dunn DT, Desai M, et al. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet. 2016;387:53–60. - PMC - PubMed
    1. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014;14:820–29. - PMC - PubMed
    1. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587–99. - PMC - PubMed
    1. Marcus JL, Glidden DV, Mayer KH, et al. No evidence of sexual risk compensation in the iPrEx trial of daily oral HIV preexposure prophylaxis. PLoS One. 2013;8:e81997. - PMC - PubMed
    1. Grant R, Hecht J, Raymond H, et al. Scale-up of pre-exposure prophylaxis in San Francisco to impact HIV incidence. CROI; Seattle, WA: Feb 23–26, 2015. p. 25.

MeSH terms

Substances